YCBD
YCBD
AMEX · Pharmaceuticals

Cbdmd Inc

$0.43
-0.02 (-3.44%)
Financial Highlights (FY 2026)
Revenue
57.27M
Net Income
-6,090,911
Gross Margin
62.4%
Profit Margin
-10.6%
Rev Growth
-18.5%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.4% 62.4% 47.5% 47.5%
Operating Margin -11.3% -10.1% 13.5% 15.0%
Profit Margin -10.6% -10.1% 12.2% 13.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 57.27M 70.23M 3.60M 4.26M
Gross Profit 35.72M 43.80M 1.71M 2.02M
Operating Income -6,453,996 -7,123,615 486.9K 638.9K
Net Income -6,090,911 -6,722,859 438.1K 574.3K
Gross Margin 62.4% 62.4% 47.5% 47.5%
Operating Margin -11.3% -10.1% 13.5% 15.0%
Profit Margin -10.6% -10.1% 12.2% 13.5%
Rev Growth -18.5% -18.5% +16.0% +23.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.68M 3.44M
Total Equity 4.26M 4.18M
D/E Ratio 0.63 0.82
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -3,093,472 -3,604,118 810.0K 832.9K
Free Cash Flow 302.1K 332.0K